Multi-Analyte

Influenza A/B (Flu A/B) Antigen/Respiratory Syncytial Virus (RSV) Antigen/Adenovirus (ADV) Antigen/Human Metapneumovirus (hMPV) Antigen/Coronavirus 2019 (COVID-19) Antigen Combo Rapid Test (Swab)

Detect Influenza A/B, RSV, Adenovirus, hMPV, and COVID-19 antigens simultaneously with our combo rapid test, streamlining respiratory infection diagnosis via nasopharyngeal swabs.

CE Certified
ISO 13485
Main image of Influenza A/B (Flu A/B) Antigen/Respiratory Syncytial Virus (RSV) Antigen/Adenovirus (ADV) Antigen/Human Metapneumovirus (hMPV) Antigen/Coronavirus 2019 (COVID-19) Antigen Combo Rapid Test (Swab)

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Comprehensive Panel

Detects multiple respiratory viruses simultaneously.

Rapid Testing

Provides quick results for timely intervention.

Easy to Use

Simple procedure, minimal training required.

Product Overview

This multi-analyte rapid diagnostic test simultaneously detects Influenza A/B, Respiratory Syncytial Virus (RSV), Adenovirus (ADV), Human Metapneumovirus (hMPV), and SARS-CoV-2 (COVID-19) antigens directly from nasopharyngeal swab samples.

Technical Specifications

Detection Target Influenza A/B, RSV, ADV, hMPV, SARS-CoV-2 antigens
Sample Type Nasopharyngeal swab
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 10-15 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect a nasopharyngeal swab sample.
  2. Insert the swab into the provided extraction buffer.
  3. Apply the extracted sample to the test device.
  4. Read and interpret results within 10-15 minutes.

Result Interpretation

Positive Result
Positive: The presence of both the control line (C) and a test line (T) for any of the target antigens indicates a positive result.
Negative Result
Negative: The presence of only the control line (C) indicates a negative result for all target antigens.
Invalid Result
Invalid: If the control line (C) is not visible, the test is invalid and should be repeated.

Frequently Asked Questions

By enabling rapid and simultaneous detection of multiple respiratory pathogens, the combo rapid test supports prompt diagnosis and targeted treatment strategies, improving patient outcomes and infection control measures.

The test assists healthcare professionals in accurately differentiating between various respiratory pathogens, aiding in appropriate treatment and prevention strategies.

Yes, the Influenza A/B/RSV/ADV/hMPV/COVID-19 Antigen Combo Rapid Test is suitable for use in both adult and pediatric populations, providing comprehensive respiratory pathogen detection across a wide range of patient demographics.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor